Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A ratiometric fluorescent reporter of mitochondrial sodium.

Nature chemical biology·2026

Same author

Organelles harbour pH gradients.

Research square·2026

Same author

Organelles harbour pH gradients.

bioRxiv : the preprint server for biology·2025

Same author

An SLC12A9-dependent ion transport mechanism maintains lysosomal osmolarity.

Developmental cell·2024

Same author

Lightly counting membrane proteins in native nanodiscs.

Nature nanotechnology·2023

Same author

A DNA nanodevice for mapping sodium at single-organelle resolution.

Nature biotechnology·2023

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Correction: Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

Koushambi Mitra¹

¹Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560-012, India. kmitra@ipc.iisc.ernet.in.

Dalton Transactions (Cambridge, England : 2003)

|June 10, 2017

Summary

This correction clarifies the use of platinum complexes as light-activated anticancer agents. It refines strategies for controlled drug activation, enhancing therapeutic precision in cancer treatment.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Related Experiment Videos

Last Updated: Feb 28, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Area of Science:

Inorganic Chemistry
Medicinal Chemistry
Photochemistry

Background:

Platinum-based drugs are vital in cancer chemotherapy.
Developing targeted drug activation methods is crucial for reducing side effects.
Photodynamic activation offers a strategy for localized drug release.

Purpose of the Study:

To correct and clarify the original publication regarding platinum complexes as photochemically activated anticancer agents.
To refine the understanding of controlled activation strategies for these agents.
To ensure accurate reporting of findings in the field of targeted cancer therapy.

Main Methods:

The correction pertains to experimental procedures and data interpretation in the original study.
Spectroscopic and analytical techniques were employed to characterize platinum complexes.
Photochemical activation studies were conducted to assess drug response.

Main Results:

The correction clarifies the mechanism of light-induced activation of platinum complexes.
It provides revised data or interpretations regarding the efficacy and selectivity of these agents.
The updated information enhances the understanding of photodynamic therapy strategies.

Conclusions:

Accurate reporting is essential for advancing the development of platinum-based photodynamic anticancer therapies.
Controlled activation strategies are key to improving the therapeutic index of platinum drugs.
This correction ensures the scientific community has precise information for future research in targeted cancer treatment.